Three generic drug makers’ challenge to the validity of a Bayer AG patent protecting its blockbuster blood-thinning drug ...

The past few months have seen announcements of prototype electric vehicles that don’t use inverters to produce three-phase ...

Hefei Lunzha's Breakthrough Patent: Significant Reduction in Installation and Disassembly Time ...

Ocean Tomo experts who deliver actionable insights that drive IP-backed business decisions recognized by IAM. JERICHO, N.Y., ...

Cameras captured a striking photograph of King Charles yesterday as he made an appearance at the Town Hall in Barrow-in-Furness, Cumbria, for the presentation of the Letters Patent formally bestowing ...

Bausch Health and Teva Pharmaceuticals were sued on Monday for allegedly conspiring to delay sales of a generic version of ...

In the final keynote address of IPWatchdog’s three-day 2025 Women’s IP Forum, the Honorable Kathleen O’Malley, former Circuit ...

Sauvegarder Investment Management ("SIM IP"), a global leader in intellectual property-based investment and monetization, is ...

Mangaluru’s Directorate of Cashew Research develops ‘Joni’ jaggery from cashew apples. Low GI, nutrient-rich and ...

Biosimilars and generics drive significant health care savings, yet a concerning lack of biosimilar development for biologics set to lose exclusivity in the next 10 years threatens future access and ...

By extending their monopoly on a drug, companies prevent generics and other competitors from driving down prices. But increasing transparency can help prevent Big Pharma from gaming the patent system.

Sheetal Janardan Patil (Pawar), Principal of the Institute of Pharmacy of Ravindra Vidya Prasarak Mandal, has received a ...